Purification of Anti-CHO-rPvs48/45 IgG
Corresponding Organization :
Other organizations : Université des Sciences, des Techniques et des Technologies de Bamako, National Institute of Allergy and Infectious Diseases, University of Lausanne, University Hospital of Lausanne, Groupe de Recherche et d’Action sur le Foncier, Caucaseco Scientific Research Center, National Institutes of Health, International Drug Development
Variable analysis
- Antibody purification method using antigen-Sepharose conjugate
- Anti-CHO-rPvs48/45 antibody titers
- Recognition of rPvs48/45 by purified antibody fractions
- Serum pool from TZ adult donors with high anti-CHO-rPvs48/45 antibody titers
- CNBr-Sepharose 4B activation with 1 mM HCl
- Coupling buffer composition (0.1 M NaHCO3 containing 0.5 M NaCl, pH 8.0)
- Dilution of sera (5-fold) with PBS (1x) containing 0.5 M sodium chloride
- Washing buffers (TRIS 20 mM containing 0.5 M NaCl, pH 8.0; TRIS 20 mM, pH 8.0)
- Elution buffer (glycine 0.1 M, pH 2.5)
- Neutralization with TRIS solution (1 M, pH 8.0)
- Dialysis against phosphate buffer (0.1 M, pH 7.0)
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!